Section Arrow
NCEL.NASDAQ
- NewcelX Ltd.
Quotes are at least 15-min delayed:2026/04/21 19:27 EDT
After Hours
Last
 3.41
+0.03 (+0.89%)
Bid
3.21
Ask
3.53
High 3.54 
Low 3.21 
Volume 3.39K 
Regular Hours (Closed)
Last
 3.38
+0.55 (+19.43%)
Day High 
3.4 
Prev. Close
2.83 
1-M High
2.85 
Volume 
204.82K 
Bid
3.21
Ask
3.53
Day Low
2.8801 
Open
2.97 
1-M Low
1.8299 
Market Cap 
14.29M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 2.43 
20-SMA 2.35 
50-SMA 2.59 
52-W High 30.799 
52-W Low 1.8299 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-20.64/1.13
Enterprise Value
14.29M
Balance Sheet
Book Value Per Share
-3.36
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1968-0.0651-24.86%-- 
After Hours 0.2115 +0.0147 +7.47%
XRTXXORTX Therapeutics Inc.2.69+0.44+19.56%-- 
After Hours 2.66 -0.03 -1.12%
TOVXTheriva Biologics Inc0.3387-0.0713-17.39%0.09PE
After Hours 0.33735 -0.00135 -0.40%
GERNGeron Corp1.5-0.06-3.85%-- 
After Hours 1.5092 +0.0092 +0.61%
SPRCSciSparc Ltd.5.99+1.76+41.61%0PE
After Hours 5.6992 -0.2908 -4.85%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.